CymaBay Therapeutics
CymaBay Therapeutics (CBAY) is a clinical-stage biopharmaceutical firm focused on improving the lives of people with liver and other chronic diseases that have a high unmet medical need through a pipeline of innovative therapies.  

The firm is proud of its deep understanding of the underlying mechanisms of liver inflammation . . .